• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Iranian Journal of Immunology
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 15 (2018)
Volume Volume 14 (2017)
Volume Volume 13 (2016)
Volume Volume 12 (2015)
Volume Volume 11 (2014)
Volume Volume 10 (2013)
Volume Volume 9 (2012)
Volume Volume 8 (2011)
Volume Volume 7 (2010)
Volume Volume 6 (2009)
Volume Volume 5 (2008)
Volume Volume 4 (2007)
Volume Volume 3 (2006)
Volume Volume 2 (2005)
Volume Volume 1 (2004)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Kasraeian, M., Movaseghii, M., Fotouhi Ghiam, A. (2004). Seroepidemiological Study of Herpes Simplex Virus Type 2 (HSV-2) Antibody in Shiraz, Iran. Iranian Journal of Immunology, 1(3), 189-193.
Maryam Kasraeian; Marjan Movaseghii; Alireza Fotouhi Ghiam. "Seroepidemiological Study of Herpes Simplex Virus Type 2 (HSV-2) Antibody in Shiraz, Iran". Iranian Journal of Immunology, 1, 3, 2004, 189-193.
Kasraeian, M., Movaseghii, M., Fotouhi Ghiam, A. (2004). 'Seroepidemiological Study of Herpes Simplex Virus Type 2 (HSV-2) Antibody in Shiraz, Iran', Iranian Journal of Immunology, 1(3), pp. 189-193.
Kasraeian, M., Movaseghii, M., Fotouhi Ghiam, A. Seroepidemiological Study of Herpes Simplex Virus Type 2 (HSV-2) Antibody in Shiraz, Iran. Iranian Journal of Immunology, 2004; 1(3): 189-193.

Seroepidemiological Study of Herpes Simplex Virus Type 2 (HSV-2) Antibody in Shiraz, Iran

Article 7, Volume 1, Issue 3, Autumn 2004, Page 189-193  XML PDF (190.28 K)
Document Type: Original Article
Authors
Maryam Kasraeian email 1; Marjan Movaseghii1; Alireza Fotouhi Ghiam2
1Department of OB/GYN, Medical School
2Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract
Background: Herpes Simplex Virus (HSV) Type 2 is a widespread human infectious agent responsible for persistent and latent infections.
Objectives:
To estimate the regional seroprevalence of anti HSV-2 antibody in Shiraz, Iran and to investigate the possible correlation of seropositivity with malignant changes in subjects’ Papanicolaou (Pap) tests.
Methods:
Data were collected in a cross-sectional study. A randomly selected population of 915 women, from nine primary health care centers according to regional population size, was recruited in this study. HSV type specific serum IgG was determined by an Enzyme Linked Immunosorbent assay.
Results: The overall seroprevalence of HSV-2 antibody was 258/915 (28.19%). Most of the seropositive cases (87.6%) were categorized in the group of less educated women. None of the individuals with positive serum antibody had malignant change in the uterine cells obtained with the help of Pap smear.
Conclusion: HSV-2 infection is relatively common and largely unrecognized among our study participants. The HSV-2 antibody was more prevalent in the studied population in comparison with European and American women, and less prevalent than African women. Although HSV-2 is reported to be in correlation with cervical cancer, none of our studied subjects had any malignant change in cervical cells.
Keywords
Cervical Cancer; Genital Herpes; HSV Type 2; pap smear; Seroprevalence
Statistics
Article View: 761
PDF Download: 573
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by sinaweb.